METABOLIC EFFECTS OF N⁶-SUBSTITUTED ADENOSINES IN RATS = LES EFFETS METABOLIQUES DES ADENOSINES N⁶-SUBSTITUEES CHEZ LES RATSSCHILLINGER E; LOGE O.1974; BIOCHEM. PHARMACOL.; G.B.; DA. 1974; VOL. 23; NO 16; PP. 2283-2289; BIBL. 21REF.Article

EFFECTS OF DERIVATIVES OF INDOLE CARBOXYLIC ACIDS ON CARBOHYDRATE METABOLISM OF THE RATSCHILLINGER E; LOGE O.1973; BIOCHEM. PHARMACOL.; G.B.; DA. 1973; VOL. 22; NO 7; PP. 841-848; BIBL. 16 REF.Serial Issue

BLOOD GLUCOSE LOWERING SULFONAMIDES WITH ASYMMETRIC CARBON ATOMS. IRUFER C; BIERE H; LOGE O et al.1974; J. MEDECIN. CHEM.; U.S.A.; DA. 1974; VOL. 17; NO 7; PP. 708-715; BIBL. 10 REF.Article

TIEREXPERIMENTELLE UNTERSUCHUNGEN ZUR WIRKUNGSWEISE DER BIGUANIDE. III. VERSUCHE MIT NICHT HYPOGLYKAEMISCH WIRKENDEN BIGUANIDDOSEN = RECHERCHES EXPERIMENTALES SUR L'ANIMAL SUR LE MODE D'ACTION DES BIGUANIDES. III. RECHERCHES AVEC DES DOSES DE BIGUANIDES NE PRESENTANT PAS D'ACTIVITE HYPOGLYCEMIANTELOSERT W; SCHILLINGER E; KRAAZ W et al.1972; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1972; VOL. 22; NO 9; PP. 1540-1552; BIBL. 7 REF.Serial Issue

SPALTUNG UND RUECKBILDUNG DER DISULFIDBRUECKEN AN INTRAMOLEKULAR VERNETZTEN INSULINEN = RUPTURE ET REFORMATION DES LIAISONS DISULFURES DANS DES INSULINES A RETICULATION INTRAMOLECULAIREROBINSON SML; BEETZ I; LOGE O et al.1973; TETRAHEDRON LETTERS; G.B.; DA. 1973; NO 12; PP. 985-988; BIBL. 6 REF.Serial Issue

TIEREXPERIMENTELLE UNTERSUCHUNGEN ZUR WIRKUNGSWEISE DER BIGUANIDE. III. VERSUCHE MIT NICHT HYPOGLYKAEMISCH WIRKENDEN BIGUANIDDOSEN = RECHERCHES EXPERIMENTALES SUR L'ANIMAL SUR LE MODE D'ACTION DES BIGUANIDES. III. RECHERCHES AVEC DES DOSES DE BIGUANIDES NE PRESENTANT PAS D'ACTIVITE HYPOGLYCEMIANTELOSERT W; SCHILLINGER E; KRAAZ W et al.1972; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1972; VOL. 22; NO 9; PP. 1540-1552; BIBL. 7 REF.Serial Issue

,15-KETALS OF NATURAL PROSTAGLANDINS AND PROSTAGLANDIN ANALOGUES. SYNTHESIS AND BIOLOGICAL ACTIVITIES.SKUBALLA W; RADUECHEL B; LOGE O et al.1978; J. MEDICIN. CHEM.; U.S.A.; DA. 1978; VOL. 21; NO 5; PP. 443-447; BIBL. 13 REF.Article

β₂-Agonists containing metabolically labile groups. II: The influence of ester groups in the aryl systemALBRECHT, R; HEINDL, J; LOGE, O et al.European journal of medicinal chemistry. 1985, Vol 20, Num 1, pp 57-60, issn 0223-5234Article

GLIFLUMIDE, A NEW ORAL ANTIDIABETIC OF HIGH POTENCY AND EFFICACY.BLUMENBACH L; GERHARDS E; GUTSCHE H et al.1975; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1975; VOL. 12; NO 1-2; PP. 141-151; BIBL. 10 REF.; (VITH INT. SYMP. CLIN. PHARMACOL.; REGENSBURG, GER.; 1974)Conference Paper

Pharmacological profile of a new potent 5-hydroxytryptamine (5-HT₂) α₁-receptor antagonistSCHRÖDER, G; BECKMANN, R; GERBLING, K. P et al.Arzneimittel-Forschung. 1988, Vol 38, Num 6, pp 765-770, issn 0004-4172Article